Nutritional supplements company Natural Alternatives International Inc (NASDAQ:NAII) reported on Wednesday the receipt of a Notice of Allowance for its instant release beta-alanine patent application entitled "Methods And Compositions For Increasing The Anaerobic Working Capacity In Tissues" from the US Patent and Trademark Office.
The US Patent and Trademark Office's new accepted application is part of the company's global patent estate covering its CarnoSyn instant release beta-alanine product.
According to the company, the new allowed claims are directed to methods of delaying muscle fatigue through supplementation with instant release beta-alanine in times and amounts to increase muscle carnosine levels beyond that obtainable through diet alone.
In addition, the claimed methods allow for a loading phase and a maintenance phase of supplementation and allows for further loading after achieving and maintaining a desired level of muscle carnosine, concluded the company.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients